These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 14668180)

  • 21. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
    Kalus JS; Moser LR
    Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree.
    Mortensen OS; Bjorner JB; Newman B; Oldenburg B; Groenvold M; Madsen JK; Andersen HR;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):37-43. PubMed ID: 17301625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary percutaneous transluminal coronary intervention compared with intravenous thrombolysis in patients with ST segment elevation myocardial infarction.
    Tungsubutra W; Tresukosol D; Krittayaphong R; Panchavinnin P; Phankingtongkhum R; Chotnaiwattarakul C
    J Med Assoc Thai; 2007 Apr; 90(4):672-8. PubMed ID: 17487120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
    Gabriel RS; White HD
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).
    Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M
    Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years.
    Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1151-6. PubMed ID: 16863605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
    Waters RE; Mahaffey KW; Granger CB; Roe MT
    Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myocardial infarction interventional procedures: primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention, rescue angioplasty, rescue excimer laser.
    Rebuzzi AG; Niccoli G; Ferrante G
    Minerva Cardioangiol; 2007 Feb; 55(1):73-82. PubMed ID: 17287682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fibrinolysis in myocardial infarction with EKG elevation. Optimization of myocardial reperfusion by treatment with antithrombotic agents].
    Jaïs C; Coste P; Labèque JN; Perron JM; Lafitte S; Zabsonré P; Roudaut R
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1259-66. PubMed ID: 11794967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvants to thrombolysis after acute myocardial infarction. Does adding antiplatelet agents, antithrombotics, or angioplasty make a difference?
    Figueredo VM; Amidon TM; Wolfe CL
    Postgrad Med; 1994 Dec; 96(8):45-51, 54. PubMed ID: 7991477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous coronary intervention for ST-elevation myocardial infarction: drug-eluting stents or bare metal stents?
    Iyengar S; Rabbani LE
    Am J Ther; 2010; 17(5):516-22. PubMed ID: 19451810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1.
    Hennekens CH
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I15-7. PubMed ID: 8156657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
    Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; Dimopoulos K; Scheller B; Armstrong PW; Di Mario C
    Eur Heart J; 2010 Sep; 31(17):2156-69. PubMed ID: 20601393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.